LEROCHOL

This brand name is authorized in United States.

Active ingredients

The drug LEROCHOL contains one active pharmaceutical ingredient (API):

`1`	Lerodalcibep UNII `1PHP3QG5PZ` - LERODALCIBEP
	Lerodalcibep is a recombinant fusion protein that binds PCSK9 with picomolar affinity. PCSK9 binds to low-density lipoprotein receptor (LDLR) on the surface of hepatocytes to promote LDLR degradation within the liver. By inhibiting the binding of PCSK9 to LDLR, lerodalcibep increases the number of LDLRs available to clear LDL-C from the blood, thereby lowering LDL-C levels.
	Read more about Lerodalcibep

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
LEROCHOL Solution for injection	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
US	FDA, National Drug Code	84685-300

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.